Radiosensitivity Enhancement using Triptorelin Conjugated Bismuth Sulfide Nanoparticles (Bi₂S₃@BSA) in Radiotherapy for Breast Cancer Cells

Figure 6

Percentage (%) of living, apoptotic, and necrotic in MCF-7 cells treated or not treated with Bi₂S₃@BSA NPs and Bi₂S₃@BSA–triptorelin induced after (a) 2 Gy, (b) 4 Gy, and (c) 6 Gy radiation doses and control (no any treatment. Error bars indicate the standard error of the mean (SEM) for n = 3 independent experiments. indicates significant difference with .

(a)

(b)

(c)